Literature DB >> 24571648

Aggregates of small nuclear ribonucleic acids (snRNAs) in Alzheimer's disease.

Chadwick M Hales1, Eric B Dammer, Ian Diner, Hong Yi, Nicholas T Seyfried, Marla Gearing, Jonathan D Glass, Thomas J Montine, Allan I Levey, James J Lah.   

Abstract

We recently discovered that protein components of the ribonucleic acid (RNA) spliceosome form cytoplasmic aggregates in Alzheimer's disease (AD) brain, resulting in widespread changes in RNA splicing. However, the involvement of small nuclear RNAs (snRNAs), also key components of the spliceosome complex, in the pathology of AD remains unknown. Using immunohistochemical staining of post-mortem human brain and spinal cord, we identified cytoplasmic tangle-shaped aggregates of snRNA in both sporadic and familial AD cases but not in aged controls or other neurodegenerative disorders. Immunofluorescence using antibodies reactive with the 2,2,7-trimethylguanosine cap of snRNAs and transmission electron microscopy demonstrated snRNA localization with tau and paired helical filaments, the main component of neurofibrillary tangles. Quantitative real-time polymerase chain reaction (PCR) showed U1 snRNA accumulation in the insoluble fraction of AD brains whereas other U snRNAs were not enriched. In combination with our previous results, these findings demonstrate that aggregates of U1 snRNA and U1 small nuclear ribonucleoproteins represent a new pathological hallmark of AD.
© 2014 International Society of Neuropathology.

Entities:  

Keywords:  2,2,7-trimethylguanosine; ALS; Alzheimer's disease; RNA spliceosome; quantitative PCR; snRNA

Mesh:

Substances:

Year:  2014        PMID: 24571648      PMCID: PMC4096308          DOI: 10.1111/bpa.12133

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  25 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  The spliceosome: design principles of a dynamic RNP machine.

Authors:  Markus C Wahl; Cindy L Will; Reinhard Lührmann
Journal:  Cell       Date:  2009-02-20       Impact factor: 41.582

Review 3.  Spliceosome structure: piece by piece.

Authors:  Dustin B Ritchie; Matthew J Schellenberg; Andrew M MacMillan
Journal:  Biochim Biophys Acta       Date:  2009-09-03

Review 4.  Tau protein pathology in neurodegenerative diseases.

Authors:  M G Spillantini; M Goedert
Journal:  Trends Neurosci       Date:  1998-10       Impact factor: 13.837

5.  Structural basis for m3G-cap-mediated nuclear import of spliceosomal UsnRNPs by snurportin1.

Authors:  Anja Strasser; Achim Dickmanns; Reinhard Lührmann; Ralf Ficner
Journal:  EMBO J       Date:  2005-05-26       Impact factor: 11.598

6.  A novel procedure for pre-embedding double immunogold-silver labeling at the ultrastructural level.

Authors:  H Yi; J Leunissen; G Shi; C Gutekunst; S Hersch
Journal:  J Histochem Cytochem       Date:  2001-03       Impact factor: 2.479

7.  Sequestration of RNA in Alzheimer's disease neurofibrillary tangles and senile plaques.

Authors:  S D Ginsberg; P B Crino; V M Lee; J H Eberwine; J Q Trojanowski
Journal:  Ann Neurol       Date:  1997-02       Impact factor: 10.422

8.  Proteomics analysis reveals novel components in the detergent-insoluble subproteome in Alzheimer's disease.

Authors:  Yair M Gozal; Duc M Duong; Marla Gearing; Dongmei Cheng; John J Hanfelt; Christopher Funderburk; Junmin Peng; James J Lah; Allan I Levey
Journal:  J Proteome Res       Date:  2009-11       Impact factor: 4.466

9.  RNA-Seq analysis of the parietal cortex in Alzheimer's disease reveals alternatively spliced isoforms related to lipid metabolism.

Authors:  James D Mills; Thomas Nalpathamkalam; Heidi I L Jacobs; Caroline Janitz; Daniele Merico; Pingzhao Hu; Michael Janitz
Journal:  Neurosci Lett       Date:  2013-01-07       Impact factor: 3.046

10.  Vesicular localization and activity-dependent trafficking of presynaptic choline transporters.

Authors:  Shawn M Ferguson; Valentina Savchenko; Subbu Apparsundaram; Melissa Zwick; Jane Wright; Craig J Heilman; Hong Yi; Allan I Levey; Randy D Blakely
Journal:  J Neurosci       Date:  2003-10-29       Impact factor: 6.167

View more
  30 in total

Review 1.  Nuclear bodies: the emerging biophysics of nucleoplasmic phases.

Authors:  Lian Zhu; Clifford P Brangwynne
Journal:  Curr Opin Cell Biol       Date:  2015-05-15       Impact factor: 8.382

2.  Aggregation properties of the small nuclear ribonucleoprotein U1-70K in Alzheimer disease.

Authors:  Ian Diner; Chadwick M Hales; Isaac Bishof; Lake Rabenold; Duc M Duong; Hong Yi; Oskar Laur; Marla Gearing; Juan Troncoso; Madhav Thambisetty; James J Lah; Allan I Levey; Nicholas T Seyfried
Journal:  J Biol Chem       Date:  2014-10-29       Impact factor: 5.157

3.  RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer's disease.

Authors:  Isaac Bishof; Eric B Dammer; Duc M Duong; Sean R Kundinger; Marla Gearing; James J Lah; Allan I Levey; Nicholas T Seyfried
Journal:  J Biol Chem       Date:  2018-05-25       Impact factor: 5.157

4.  Characterization of Detergent Insoluble Proteome in Chronic Traumatic Encephalopathy.

Authors:  Jonathan D Cherry; Ahmad Zeineddin; Eric B Dammer; James A Webster; Duc Duong; Nicholas T Seyfried; Allan I Levey; Victor E Alvarez; Bertrand R Huber; Thor D Stein; Patrick T Kiernan; Ann C McKee; James J Lah; Chadwick M Hales
Journal:  J Neuropathol Exp Neurol       Date:  2018-01-01       Impact factor: 3.685

5.  Delta-Secretase Phosphorylation by SRPK2 Enhances Its Enzymatic Activity, Provoking Pathogenesis in Alzheimer's Disease.

Authors:  Zhi-Hao Wang; Pai Liu; Xia Liu; Fredric P Manfredsson; Ivette M Sandoval; Shan Ping Yu; Jian-Zhi Wang; Keqiang Ye
Journal:  Mol Cell       Date:  2017-08-17       Impact factor: 17.970

6.  Changes in the detergent-insoluble brain proteome linked to amyloid and tau in Alzheimer's Disease progression.

Authors:  Chadwick M Hales; Eric B Dammer; Qiudong Deng; Duc M Duong; Marla Gearing; Juan C Troncoso; Madhav Thambisetty; James J Lah; Joshua M Shulman; Allan I Levey; Nicholas T Seyfried
Journal:  Proteomics       Date:  2016-12       Impact factor: 3.984

Review 7.  Alternative splicing in Alzheimer's disease.

Authors:  Angela Amato; Elisa Belloni; Anna Di Matteo; Lucia Infantino; Davide Pradella; Giuseppe Biamonti; Claudia Ghigna
Journal:  Aging Clin Exp Res       Date:  2019-10-03       Impact factor: 3.636

8.  A Preliminary Study: PS1 Increases U1 snRNA Expression Associated with AD.

Authors:  Zhi Cheng; Zhanqiang Du; Yingchun Shang; Yuling Zhang; Tao Zhang
Journal:  J Mol Neurosci       Date:  2017-06-03       Impact factor: 3.444

Review 9.  Tau-mediated dysregulation of RNA: Evidence for a common molecular mechanism of toxicity in frontotemporal dementia and other tauopathies.

Authors:  Shon A Koren; Sara Galvis-Escobar; Jose F Abisambra
Journal:  Neurobiol Dis       Date:  2020-05-12       Impact factor: 5.996

10.  Tau aggregates are RNA-protein assemblies that mislocalize multiple nuclear speckle components.

Authors:  Evan Lester; Felicia K Ooi; Nadine Bakkar; Jacob Ayers; Amanda L Woerman; Joshua Wheeler; Robert Bowser; George A Carlson; Stanley B Prusiner; Roy Parker
Journal:  Neuron       Date:  2021-04-12       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.